Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Psychotic Disorders | 18 | 2023 | 3040 | 2.050 |
Why?
|
Schizophrenia | 36 | 2022 | 6874 | 1.990 |
Why?
|
Prefrontal Cortex | 16 | 2021 | 2146 | 1.400 |
Why?
|
Bipolar Disorder | 23 | 2020 | 5024 | 1.320 |
Why?
|
Aspartic Acid | 5 | 2021 | 574 | 1.240 |
Why?
|
Creatine | 6 | 2021 | 421 | 0.960 |
Why?
|
Schizophrenic Psychology | 10 | 2016 | 1677 | 0.930 |
Why?
|
Magnetic Resonance Spectroscopy | 11 | 2021 | 3760 | 0.800 |
Why?
|
Glutamic Acid | 4 | 2021 | 1167 | 0.800 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2019 | 1123 | 0.680 |
Why?
|
Cognition Disorders | 8 | 2020 | 4030 | 0.660 |
Why?
|
Olfactory Perception | 1 | 2018 | 54 | 0.620 |
Why?
|
Touch Perception | 1 | 2018 | 114 | 0.560 |
Why?
|
Neuroglia | 5 | 2008 | 925 | 0.540 |
Why?
|
Independent Living | 1 | 2020 | 564 | 0.530 |
Why?
|
Delusions | 1 | 2018 | 300 | 0.530 |
Why?
|
Hallucinations | 1 | 2018 | 360 | 0.520 |
Why?
|
Phosphorus | 2 | 2017 | 338 | 0.510 |
Why?
|
Pattern Recognition, Visual | 3 | 2011 | 823 | 0.490 |
Why?
|
Choline | 2 | 2021 | 487 | 0.490 |
Why?
|
Reward | 4 | 2020 | 940 | 0.460 |
Why?
|
Social Behavior | 1 | 2020 | 1128 | 0.450 |
Why?
|
Creatine Kinase | 2 | 2021 | 694 | 0.450 |
Why?
|
Brain | 14 | 2020 | 26343 | 0.400 |
Why?
|
Neural Pathways | 7 | 2019 | 2971 | 0.390 |
Why?
|
Models, Neurological | 4 | 2022 | 1771 | 0.390 |
Why?
|
Central Nervous System Stimulants | 2 | 2019 | 1148 | 0.380 |
Why?
|
Facial Expression | 3 | 2011 | 508 | 0.370 |
Why?
|
Illusions | 1 | 2010 | 60 | 0.370 |
Why?
|
Brain Mapping | 8 | 2019 | 6669 | 0.370 |
Why?
|
Biological Psychiatry | 1 | 2019 | 25 | 0.350 |
Why?
|
Glycine Dehydrogenase (Decarboxylating) | 1 | 2019 | 15 | 0.350 |
Why?
|
Glycine Agents | 1 | 2019 | 17 | 0.350 |
Why?
|
Glycine | 2 | 2019 | 671 | 0.330 |
Why?
|
Perceptual Disorders | 1 | 2010 | 196 | 0.330 |
Why?
|
Field Dependence-Independence | 1 | 2008 | 25 | 0.320 |
Why?
|
Affective Disorders, Psychotic | 1 | 2019 | 191 | 0.310 |
Why?
|
Behavior, Addictive | 1 | 2013 | 460 | 0.310 |
Why?
|
Anesthesia | 1 | 2019 | 1548 | 0.300 |
Why?
|
Electroshock | 1 | 2007 | 122 | 0.300 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2736 | 0.300 |
Why?
|
Gyrus Cinguli | 7 | 2017 | 1088 | 0.290 |
Why?
|
Occipital Lobe | 5 | 2019 | 380 | 0.280 |
Why?
|
Orientation | 1 | 2008 | 327 | 0.280 |
Why?
|
Depressive Disorder, Major | 7 | 2021 | 4628 | 0.270 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 2022 | 895 | 0.270 |
Why?
|
Phosphocreatine | 2 | 2017 | 269 | 0.260 |
Why?
|
Face | 4 | 2016 | 993 | 0.260 |
Why?
|
Psychomotor Performance | 3 | 2010 | 1895 | 0.260 |
Why?
|
Personality Inventory | 2 | 2005 | 1026 | 0.260 |
Why?
|
Adult | 51 | 2022 | 213712 | 0.260 |
Why?
|
Emotions | 5 | 2011 | 2657 | 0.250 |
Why?
|
Visual Perception | 4 | 2009 | 1417 | 0.240 |
Why?
|
Temporal Lobe | 4 | 2019 | 1669 | 0.240 |
Why?
|
Neuropsychological Tests | 8 | 2020 | 6974 | 0.240 |
Why?
|
Motion Perception | 1 | 2008 | 408 | 0.230 |
Why?
|
Personality Disorders | 2 | 2005 | 708 | 0.230 |
Why?
|
Male | 59 | 2021 | 349538 | 0.230 |
Why?
|
Depressive Disorder | 3 | 2020 | 3748 | 0.230 |
Why?
|
Psychotropic Drugs | 1 | 2019 | 893 | 0.230 |
Why?
|
Nicotine | 2 | 2018 | 677 | 0.220 |
Why?
|
Alcoholism | 1 | 2013 | 1904 | 0.220 |
Why?
|
Hippocampus | 4 | 2015 | 3661 | 0.220 |
Why?
|
Memory Disorders | 2 | 2008 | 1183 | 0.210 |
Why?
|
Psychiatric Status Rating Scales | 9 | 2018 | 6030 | 0.210 |
Why?
|
Somatosensory Disorders | 1 | 2022 | 47 | 0.200 |
Why?
|
Humans | 78 | 2023 | 742088 | 0.200 |
Why?
|
Cerebral Cortex | 5 | 2018 | 5705 | 0.200 |
Why?
|
Female | 54 | 2021 | 379592 | 0.200 |
Why?
|
Religion and Psychology | 1 | 2013 | 171 | 0.200 |
Why?
|
Antipsychotic Agents | 5 | 2017 | 3058 | 0.190 |
Why?
|
Macaca fascicularis | 3 | 2000 | 908 | 0.190 |
Why?
|
Learning | 1 | 2020 | 1705 | 0.180 |
Why?
|
Case-Control Studies | 11 | 2022 | 21719 | 0.180 |
Why?
|
Altitude | 1 | 2021 | 161 | 0.180 |
Why?
|
Nerve Tissue Proteins | 3 | 2015 | 4465 | 0.180 |
Why?
|
Mental Disorders | 3 | 2022 | 6587 | 0.180 |
Why?
|
Adenosine Triphosphate | 2 | 2017 | 2024 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 22 | 2021 | 35342 | 0.170 |
Why?
|
Oligodendroglia | 2 | 2018 | 514 | 0.170 |
Why?
|
Adaptation, Psychological | 2 | 2016 | 2575 | 0.170 |
Why?
|
Electroconvulsive Therapy | 1 | 2004 | 472 | 0.170 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 4328 | 0.170 |
Why?
|
Memory, Short-Term | 2 | 2019 | 972 | 0.170 |
Why?
|
Attention | 2 | 2017 | 2396 | 0.170 |
Why?
|
Hallucinogens | 1 | 2022 | 180 | 0.160 |
Why?
|
Psychoses, Substance-Induced | 1 | 2019 | 96 | 0.160 |
Why?
|
Young Adult | 19 | 2021 | 56350 | 0.160 |
Why?
|
Stress, Psychological | 3 | 2021 | 4229 | 0.160 |
Why?
|
Cognition | 5 | 2017 | 6722 | 0.160 |
Why?
|
Neurotransmitter Agents | 2 | 2019 | 647 | 0.160 |
Why?
|
Amphetamine | 1 | 2019 | 225 | 0.150 |
Why?
|
Anticipation, Psychological | 1 | 2018 | 87 | 0.150 |
Why?
|
Limbic System | 1 | 2000 | 426 | 0.150 |
Why?
|
Reaction Time | 6 | 2017 | 2092 | 0.150 |
Why?
|
Rats, Sprague-Dawley | 5 | 2019 | 8300 | 0.150 |
Why?
|
Social Perception | 3 | 2016 | 424 | 0.140 |
Why?
|
Anxiety Disorders | 2 | 2005 | 2684 | 0.140 |
Why?
|
Cues | 2 | 2018 | 868 | 0.140 |
Why?
|
Caudate Nucleus | 1 | 2017 | 393 | 0.140 |
Why?
|
Marital Status | 1 | 2018 | 437 | 0.140 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2005 | 1442 | 0.140 |
Why?
|
Corpus Callosum | 1 | 2020 | 737 | 0.130 |
Why?
|
Corpus Striatum | 2 | 2018 | 1220 | 0.130 |
Why?
|
Nicotinic Agonists | 1 | 2017 | 271 | 0.130 |
Why?
|
Tobacco Use Disorder | 2 | 2018 | 685 | 0.130 |
Why?
|
Cannabis | 1 | 2022 | 432 | 0.130 |
Why?
|
Glutamine | 1 | 2008 | 574 | 0.130 |
Why?
|
Middle Aged | 29 | 2021 | 213127 | 0.130 |
Why?
|
Methylphenidate | 1 | 2019 | 473 | 0.130 |
Why?
|
Neurons | 6 | 2021 | 9325 | 0.120 |
Why?
|
Seizures | 1 | 2007 | 2851 | 0.120 |
Why?
|
Age of Onset | 2 | 2015 | 3266 | 0.120 |
Why?
|
Cadherins | 1 | 2019 | 906 | 0.120 |
Why?
|
Interneurons | 1 | 2019 | 576 | 0.120 |
Why?
|
Therapy, Computer-Assisted | 1 | 2016 | 277 | 0.120 |
Why?
|
Psychiatry | 2 | 2022 | 1695 | 0.120 |
Why?
|
Rats | 6 | 2019 | 24265 | 0.110 |
Why?
|
Phosphates | 1 | 2017 | 786 | 0.110 |
Why?
|
Disease Progression | 1 | 2010 | 13256 | 0.110 |
Why?
|
Analysis of Variance | 4 | 2016 | 6365 | 0.110 |
Why?
|
Calcium Channels, L-Type | 1 | 2014 | 238 | 0.110 |
Why?
|
Happiness | 2 | 2011 | 170 | 0.110 |
Why?
|
Child Abuse | 1 | 2022 | 1030 | 0.110 |
Why?
|
Hypothalamus | 1 | 1998 | 1063 | 0.110 |
Why?
|
Amygdala | 5 | 2019 | 1305 | 0.110 |
Why?
|
Suicide | 1 | 2013 | 1475 | 0.110 |
Why?
|
Severity of Illness Index | 4 | 2018 | 15530 | 0.100 |
Why?
|
Energy Metabolism | 4 | 2017 | 2896 | 0.100 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2019 | 3649 | 0.100 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 3 | 2008 | 1953 | 0.100 |
Why?
|
Behavior Therapy | 1 | 2017 | 866 | 0.100 |
Why?
|
Membrane Potentials | 1 | 2014 | 1135 | 0.100 |
Why?
|
Functional Laterality | 2 | 2010 | 2290 | 0.100 |
Why?
|
Cell Proliferation | 1 | 2007 | 10472 | 0.100 |
Why?
|
Visual Cortex | 1 | 2019 | 1149 | 0.100 |
Why?
|
Signal Detection, Psychological | 2 | 2008 | 85 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2019 | 1728 | 0.090 |
Why?
|
Photic Stimulation | 3 | 2015 | 2027 | 0.090 |
Why?
|
Diffusion Tensor Imaging | 1 | 2020 | 2304 | 0.090 |
Why?
|
Educational Status | 1 | 2018 | 2533 | 0.090 |
Why?
|
Adolescent | 13 | 2022 | 85649 | 0.090 |
Why?
|
National Institute of Mental Health (U.S.) | 1 | 2019 | 106 | 0.090 |
Why?
|
Discrimination Learning | 2 | 2008 | 280 | 0.090 |
Why?
|
Regression Analysis | 3 | 2015 | 6452 | 0.080 |
Why?
|
Neurogenesis | 1 | 2015 | 829 | 0.080 |
Why?
|
Optical Illusions | 1 | 2008 | 40 | 0.080 |
Why?
|
Spectrum Analysis | 1 | 2010 | 451 | 0.080 |
Why?
|
Protons | 2 | 2010 | 1126 | 0.080 |
Why?
|
Parietal Lobe | 2 | 2008 | 837 | 0.080 |
Why?
|
Electron Transport Chain Complex Proteins | 1 | 2007 | 38 | 0.080 |
Why?
|
Myelin Sheath | 2 | 2018 | 652 | 0.070 |
Why?
|
Natural Language Processing | 1 | 2014 | 1035 | 0.070 |
Why?
|
Bromodeoxyuridine | 1 | 2007 | 322 | 0.070 |
Why?
|
Pain | 1 | 2022 | 4961 | 0.070 |
Why?
|
Neural Inhibition | 1 | 2010 | 598 | 0.070 |
Why?
|
Task Performance and Analysis | 1 | 2010 | 780 | 0.070 |
Why?
|
Thalamic Diseases | 1 | 2005 | 16 | 0.070 |
Why?
|
Radionuclide Imaging | 1 | 2010 | 2027 | 0.070 |
Why?
|
Sex Characteristics | 1 | 2016 | 2585 | 0.070 |
Why?
|
Nerve Net | 3 | 2010 | 2174 | 0.070 |
Why?
|
Tissue Distribution | 1 | 2010 | 2335 | 0.070 |
Why?
|
Fear | 2 | 2011 | 1436 | 0.070 |
Why?
|
Psychopharmacology | 1 | 2007 | 143 | 0.060 |
Why?
|
Cell Count | 2 | 2007 | 1831 | 0.060 |
Why?
|
Cerebellum | 2 | 2010 | 1490 | 0.060 |
Why?
|
Drug Synergism | 1 | 2019 | 1791 | 0.060 |
Why?
|
Panic Disorder | 1 | 2008 | 616 | 0.060 |
Why?
|
Congresses as Topic | 1 | 2019 | 764 | 0.060 |
Why?
|
Random Allocation | 1 | 2019 | 2425 | 0.060 |
Why?
|
Marijuana Abuse | 1 | 2008 | 402 | 0.060 |
Why?
|
Smoking | 2 | 2018 | 8969 | 0.060 |
Why?
|
Reference Values | 3 | 2008 | 4982 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2010 | 8925 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2016 | 62966 | 0.060 |
Why?
|
Comorbidity | 3 | 2008 | 10372 | 0.060 |
Why?
|
Proteoglycans | 1 | 2007 | 834 | 0.060 |
Why?
|
Double-Blind Method | 3 | 2019 | 12017 | 0.060 |
Why?
|
Sex Factors | 2 | 2015 | 10392 | 0.060 |
Why?
|
Acetylcholinesterase | 1 | 2003 | 153 | 0.060 |
Why?
|
Synaptic Transmission | 2 | 2008 | 1179 | 0.060 |
Why?
|
Macaca nemestrina | 2 | 2000 | 23 | 0.050 |
Why?
|
Animals | 12 | 2019 | 168561 | 0.050 |
Why?
|
Synapses | 2 | 2019 | 1724 | 0.050 |
Why?
|
Amidines | 2 | 1998 | 30 | 0.050 |
Why?
|
Cross-Over Studies | 2 | 2018 | 2030 | 0.050 |
Why?
|
Age Factors | 2 | 2018 | 18355 | 0.050 |
Why?
|
Time Factors | 4 | 2016 | 40054 | 0.050 |
Why?
|
United States | 4 | 2022 | 69693 | 0.050 |
Why?
|
Parvalbumins | 1 | 2003 | 246 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 3915 | 0.050 |
Why?
|
Tritium | 2 | 1998 | 746 | 0.050 |
Why?
|
Rhodamines | 2 | 1998 | 183 | 0.050 |
Why?
|
Utah | 1 | 2021 | 126 | 0.050 |
Why?
|
Neurofilament Proteins | 1 | 2003 | 318 | 0.050 |
Why?
|
Antigens | 1 | 2007 | 1462 | 0.050 |
Why?
|
Glucose | 2 | 2007 | 4391 | 0.050 |
Why?
|
Biotin | 2 | 1998 | 253 | 0.050 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2010 | 1431 | 0.050 |
Why?
|
Information Dissemination | 1 | 2019 | 1100 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 2866 | 0.050 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 1940 | 0.050 |
Why?
|
Neurotoxicity Syndromes | 1 | 2004 | 290 | 0.050 |
Why?
|
Leucine | 2 | 1998 | 560 | 0.050 |
Why?
|
Dextrans | 2 | 1998 | 592 | 0.040 |
Why?
|
Demography | 1 | 2005 | 1650 | 0.040 |
Why?
|
Oxygen | 3 | 2007 | 4169 | 0.040 |
Why?
|
Thalamus | 1 | 2005 | 1023 | 0.040 |
Why?
|
Haplorhini | 1 | 2000 | 551 | 0.040 |
Why?
|
Teaching | 1 | 2007 | 1174 | 0.040 |
Why?
|
Macaca | 1 | 2000 | 440 | 0.040 |
Why?
|
Lymphocytes | 1 | 2007 | 2614 | 0.040 |
Why?
|
Psychopathology | 1 | 2022 | 402 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2003 | 1099 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6483 | 0.040 |
Why?
|
Quality of Life | 1 | 2020 | 12730 | 0.040 |
Why?
|
Periaqueductal Gray | 1 | 1998 | 107 | 0.040 |
Why?
|
Insulin | 1 | 2013 | 6575 | 0.040 |
Why?
|
Research Design | 2 | 2019 | 5979 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2014 | 4440 | 0.040 |
Why?
|
Matched-Pair Analysis | 1 | 2008 | 288 | 0.040 |
Why?
|
Mutation | 1 | 2022 | 29717 | 0.040 |
Why?
|
Putamen | 1 | 1998 | 291 | 0.040 |
Why?
|
Contrast Sensitivity | 2 | 2009 | 244 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2885 | 0.040 |
Why?
|
Mood Disorders | 1 | 2004 | 1106 | 0.040 |
Why?
|
Mental Recall | 1 | 2023 | 1205 | 0.040 |
Why?
|
Ambulatory Care Facilities | 1 | 2023 | 932 | 0.040 |
Why?
|
Neuronal Plasticity | 2 | 2016 | 1418 | 0.040 |
Why?
|
Substantia Nigra | 1 | 1998 | 353 | 0.040 |
Why?
|
Autonomic Nervous System | 2 | 1998 | 671 | 0.040 |
Why?
|
Phenotype | 2 | 2020 | 16331 | 0.040 |
Why?
|
Aged | 7 | 2014 | 162944 | 0.030 |
Why?
|
Massachusetts | 2 | 2021 | 8662 | 0.030 |
Why?
|
Signal Transduction | 1 | 2019 | 23387 | 0.030 |
Why?
|
Species Specificity | 1 | 2000 | 2479 | 0.030 |
Why?
|
Ambulatory Care | 2 | 2022 | 2706 | 0.030 |
Why?
|
Genotype | 1 | 2020 | 12946 | 0.030 |
Why?
|
Calcium Channel Agonists | 1 | 2014 | 29 | 0.030 |
Why?
|
Chronic Disease | 1 | 2010 | 9144 | 0.030 |
Why?
|
Social Adjustment | 1 | 2017 | 630 | 0.030 |
Why?
|
Organ Size | 2 | 2016 | 2253 | 0.030 |
Why?
|
Dystonia | 1 | 1998 | 363 | 0.030 |
Why?
|
Outpatients | 1 | 2022 | 1483 | 0.030 |
Why?
|
Cholesterol | 1 | 2004 | 2895 | 0.030 |
Why?
|
Pilot Projects | 2 | 2017 | 8297 | 0.030 |
Why?
|
Thalamic Nuclei | 1 | 1995 | 114 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 2021 | 1310 | 0.030 |
Why?
|
Mitochondria | 1 | 2007 | 3520 | 0.030 |
Why?
|
Fluorescent Dyes | 2 | 1998 | 1915 | 0.030 |
Why?
|
Motor Neurons | 1 | 1998 | 851 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2021 | 1402 | 0.030 |
Why?
|
Haloperidol | 1 | 1995 | 397 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2015 | 599 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1995 | 575 | 0.030 |
Why?
|
Data Collection | 1 | 2021 | 3339 | 0.030 |
Why?
|
Administration, Intranasal | 1 | 2013 | 446 | 0.030 |
Why?
|
Clozapine | 1 | 1995 | 498 | 0.030 |
Why?
|
Transduction, Genetic | 1 | 2014 | 913 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2005 | 3507 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2014 | 1341 | 0.020 |
Why?
|
Behavior, Animal | 1 | 1998 | 1882 | 0.020 |
Why?
|
China | 1 | 2016 | 2246 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2372 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2016 | 1459 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2017 | 19862 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39004 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2018 | 11470 | 0.020 |
Why?
|
Neck Pain | 1 | 2010 | 179 | 0.020 |
Why?
|
Kinetics | 1 | 2017 | 6474 | 0.020 |
Why?
|
Theta Rhythm | 1 | 2010 | 207 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3300 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 12071 | 0.020 |
Why?
|
Acute Disease | 1 | 2008 | 7141 | 0.020 |
Why?
|
Motor Activity | 1 | 2017 | 2714 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1675 | 0.020 |
Why?
|
Cohort Studies | 3 | 2019 | 40450 | 0.020 |
Why?
|
Astrocytes | 1 | 2014 | 1266 | 0.020 |
Why?
|
Depression | 2 | 2015 | 7733 | 0.020 |
Why?
|
Internship and Residency | 1 | 2007 | 5774 | 0.020 |
Why?
|
Motivation | 1 | 2016 | 1968 | 0.020 |
Why?
|
Insurance, Health | 1 | 2019 | 2493 | 0.020 |
Why?
|
Electron Transport | 1 | 2007 | 211 | 0.020 |
Why?
|
Feeding Behavior | 1 | 1998 | 3187 | 0.020 |
Why?
|
Algorithms | 2 | 2017 | 13853 | 0.020 |
Why?
|
Psychological Tests | 1 | 2007 | 648 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2007 | 411 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2006 | 24913 | 0.020 |
Why?
|
Tomography, Emission-Computed | 2 | 1998 | 1144 | 0.020 |
Why?
|
Exploratory Behavior | 1 | 2005 | 270 | 0.020 |
Why?
|
Cell Line | 1 | 2018 | 15994 | 0.010 |
Why?
|
Fibroblasts | 1 | 2014 | 4143 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 7716 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14554 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3062 | 0.010 |
Why?
|
Computer Simulation | 1 | 2017 | 6191 | 0.010 |
Why?
|
Reference Standards | 1 | 2007 | 1020 | 0.010 |
Why?
|
California | 1 | 2007 | 1400 | 0.010 |
Why?
|
Factor Analysis, Statistical | 1 | 2005 | 975 | 0.010 |
Why?
|
Headache | 1 | 2010 | 1219 | 0.010 |
Why?
|
Neurosciences | 1 | 2007 | 347 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 1 | 2007 | 1097 | 0.010 |
Why?
|
Models, Statistical | 1 | 2017 | 5100 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10232 | 0.010 |
Why?
|
Administration, Oral | 1 | 2009 | 3913 | 0.010 |
Why?
|
Calcium | 1 | 2014 | 5753 | 0.010 |
Why?
|
Entorhinal Cortex | 1 | 2002 | 264 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 20928 | 0.010 |
Why?
|
Cell Size | 1 | 2002 | 643 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2022 | 17400 | 0.010 |
Why?
|
Valproic Acid | 1 | 2002 | 446 | 0.010 |
Why?
|
Down-Regulation | 1 | 2007 | 3001 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14720 | 0.010 |
Why?
|
Serotonin | 1 | 2004 | 1024 | 0.010 |
Why?
|
Lithium | 1 | 2002 | 601 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 40955 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15056 | 0.010 |
Why?
|
Prospective Studies | 1 | 2013 | 53187 | 0.010 |
Why?
|
Mesencephalon | 1 | 2000 | 327 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2015 | 4248 | 0.010 |
Why?
|
Orbit | 1 | 2000 | 427 | 0.010 |
Why?
|
Cholera Toxin | 1 | 1998 | 553 | 0.010 |
Why?
|
Neurons, Afferent | 1 | 1998 | 508 | 0.010 |
Why?
|
Ritanserin | 1 | 1995 | 9 | 0.010 |
Why?
|
Sulpiride | 1 | 1995 | 17 | 0.010 |
Why?
|
Prazosin | 1 | 1995 | 96 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2007 | 3611 | 0.010 |
Why?
|
Scopolamine | 1 | 1995 | 99 | 0.010 |
Why?
|
Blood Pressure | 1 | 2010 | 8541 | 0.010 |
Why?
|
Serotonin Antagonists | 1 | 1995 | 146 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12164 | 0.010 |
Why?
|
Muscarinic Antagonists | 1 | 1995 | 137 | 0.010 |
Why?
|
Curriculum | 1 | 2007 | 3589 | 0.010 |
Why?
|
Child | 1 | 2022 | 77478 | 0.010 |
Why?
|
Family Health | 1 | 1998 | 1282 | 0.010 |
Why?
|
Blood Glucose | 1 | 2007 | 6249 | 0.010 |
Why?
|
Anticonvulsants | 1 | 2002 | 1914 | 0.010 |
Why?
|
Observer Variation | 1 | 1998 | 2593 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5851 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2004 | 2838 | 0.010 |
Why?
|
Mice | 1 | 2019 | 81045 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2007 | 19223 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 9410 | 0.010 |
Why?
|
Blotting, Western | 1 | 1995 | 5180 | 0.000 |
Why?
|
Skin | 1 | 2000 | 4353 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1995 | 11363 | 0.000 |
Why?
|